(4-fluorophenyl) N-[3-fluoro-4-[6-(1-methylimidazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]oxyphenyl]carbamate
C24H17F2N5O3 — CID 118203835
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4-fluorophenyl) N-[3-fluoro-4-[6-(1-methylimidazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]oxyphenyl]carbamate
(4-fluorophenyl) N-[3-fluoro-4-[6-(1-methylimidazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]oxyphenyl]carbamate (PubChem CID 118203835) has the molecular formula C24H17F2N5O3 and a molecular weight of 461.43 g/mol. Its IUPAC name is (4-fluorophenyl) N-[3-fluoro-4-[6-(1-methylimidazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]oxyphenyl]carbamate.
Molecular Properties
| Compound Name | (4-fluorophenyl) N-[3-fluoro-4-[6-(1-methylimidazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]oxyphenyl]carbamate |
|---|---|
| PubChem CID | 118203835 |
| Molecular Formula | C24H17F2N5O3 |
| Molecular Weight | 461.43 g/mol |
| Exact Mass | 461.13 |
| IUPAC Name | (4-fluorophenyl) N-[3-fluoro-4-[6-(1-methylimidazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]oxyphenyl]carbamate |
| SMILES | Cn1cnc(-c2cc(Oc3ccc(NC(=O)Oc4ccc(F)cc4)cc3F)c3ccnn3c2)c1 |
| InChI | InChI=1S/C24H17F2N5O3/c1-30-13-20(27-14-30)15-10-23(21-8-9-28-31(21)12-15)34-22-7-4-17(11-19(22)26)29-24(32)33-18-5-2-16(25)3-6-18/h2-14H,1H3,(H,29,32) |
| InChIKey | NUGVUGOMPMILKH-UHFFFAOYSA-N |
| XLogP | 5.42 |
| TPSA | 82.68 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 461.43 |
| LogP ≤ 5 | 5.42 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118203835 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.